Publications by authors named "Paul B Card"

Claim this Profile
C
Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines.
Christine Simmons, Daniel Rayson, Anil Abraham Joy, Jan-Willem Henning, Julie Lemieux, Paul B Card

Ther Adv Med Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The rapidly evolving landscape of novel targeted therapies in advanced non-small cell lung cancer.
Barbara Melosky, Paul Wheatley-Price, Rosalyn A Juergens, Adrian Sacher, Natasha B Leighl, Paul B Card

Lung Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Survival and the Changing Landscape of Targeted Therapy for Intermediate and Advanced Hepatocellular Carcinoma: A Systematic Review.
Howard Lim, Ravi Ramjeesingh, Dave Liu, Vincent C Tam, Jennifer J Knox, Paul B Card

J Natl Cancer Inst· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amplifying Outcomes: Checkpoint Inhibitor Combinations in First-Line Non-Small Cell Lung Cancer.
Barbara Melosky, Rosalyn Juergens, Vera Hirsh, Deanna McLeod, Natasha Leighl, Paul B Card

Oncologist· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint-inhibitors and chemoradiation in stage III unresectable non-small cell lung cancer.
Barbara Melosky, Rosalyn Juergens, Deanna McLeod, Natasha Leighl, Anthony Brade, Paul B Card

Lung Cancer· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulating the ARNT/TACC3 axis: multiple approaches to manipulating protein/protein interactions with small molecules.
Yirui Guo, Carrie L Partch, Jason Key, Paul B Card, Victor Pashkov

ACS Chem Biol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular basis of coiled coil coactivator recruitment by the aryl hydrocarbon receptor nuclear translocator (ARNT).
Carrie L Partch, Paul B Card, Carlos A Amezcua, Kevin H Gardner

J Biol Chem· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ARNT PAS-B has a fragile native state structure with an alternative beta-sheet register nearby in sequence space.
Matthew R Evans, Paul B Card, Kevin H Gardner

Proc Natl Acad Sci U S A· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural basis of ARNT PAS-B dimerization: use of a common beta-sheet interface for hetero- and homodimerization.
Paul B Card, Paul J A Erbel, Kevin H Gardner

J Mol Biol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and optimization of protein domains for NMR studies.
Paul B Card, Kevin H Gardner

Methods Enzymol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural basis for PAS domain heterodimerization in the basic helix--loop--helix-PAS transcription factor hypoxia-inducible factor.
Paul J A Erbel, Paul B Card, Ozgur Karakuzu, Richard K Bruick, Kevin H Gardner

Proc Natl Acad Sci U S A· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis